QR-koodi

A VAMS‐based LC–MS/MS method for precise cenobamate quantification in epilepsy (patients)

Abstract Objective Cenobamate (CNB), a recently approved antiseizure medication by the European Medicines Agency (EMA), serves as an adjunctive therapy for focal‐onset seizures in adult patients unresponsive to at least two other treatments. Administered in polytherapy, CNB can potentially interact...

Täydet tiedot

Tallennettuna:
Päätekijät: Federica Pigliasco, Alessia Cafaro, Sebastiano Barco, Margherita Biondi, Manuela Stella, Francesca Mattioli, Antonella Riva, Ugo deGrazia, Linda Molteni, Elisa Micalizzi, Flavio Villani, Pasquale Striano, Roberto Bandettini, Giuliana Cangemi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wiley 2024-12-01
Sarja:Epilepsia Open
Aiheet:
antiseizure medications
cenobamate
drug monitoring
liquid chromatography tandem‐mass spectrometry
volumetric absorptive microsampling
Linkit:https://doi.org/10.1002/epi4.12927
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia